Findlay Park Partners LLP Sells 150,000 Shares of Danaher Co. (NYSE:DHR)
Findlay Park Partners LLP decreased its position in Danaher Co. (NYSE:DHR) by 3.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,675,000 shares of the conglomerate’s stock after selling 150,000 shares during the quarter. Danaher comprises approximately 3.5% of Findlay Park Partners LLP’s holdings, making the stock its 11th largest position. Findlay Park Partners LLP owned approximately 0.52% of Danaher worth $399,326,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. IMS Capital Management acquired a new position in shares of Danaher during the 2nd quarter valued at about $107,000. BerganKDV Wealth Management LLC acquired a new position in shares of Danaher during the 2nd quarter valued at about $111,000. Fort L.P. acquired a new position in shares of Danaher during the 2nd quarter valued at about $119,000. Braun Bostich & Associates Inc. increased its holdings in shares of Danaher by 506.4% during the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after acquiring an additional 1,023 shares during the last quarter. Finally, Reilly Financial Advisors LLC boosted its stake in Danaher by 62.6% during the 3rd quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after purchasing an additional 501 shares during the period. 77.13% of the stock is owned by institutional investors and hedge funds.
In other news, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $95.77, for a total value of $1,013,055.06. Following the transaction, the director now directly owns 105,491 shares in the company, valued at approximately $10,102,873.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Robert S. Lutz sold 15,000 shares of the firm’s stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $103.80, for a total value of $1,557,000.00. Following the completion of the transaction, the senior vice president now owns 33,044 shares in the company, valued at $3,429,967.20. The disclosure for this sale can be found here. Insiders sold a total of 150,007 shares of company stock valued at $15,202,163 over the last three months. Insiders own 11.90% of the company’s stock.
Danaher (NYSE:DHR) last released its earnings results on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.03. The company had revenue of $4.85 billion during the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $1.00 EPS. Equities research analysts forecast that Danaher Co. will post 4.51 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Stockholders of record on Friday, December 28th will be paid a $0.16 dividend. The ex-dividend date is Thursday, December 27th. This represents a $0.64 annualized dividend and a dividend yield of 0.60%. Danaher’s dividend payout ratio (DPR) is currently 15.88%.
A number of analysts have commented on DHR shares. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Friday, October 12th. Morgan Stanley raised their price objective on Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 10th. Finally, Robert W. Baird cut their target price on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research report on Friday, October 19th. One equities research analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $112.14.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Further Reading: Institutional Investors
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.